Related Articles
Evaluation of whole-body retention of iodine-131 (131I) after postoperative remnant ablation for differentiated thyroid carcinoma – thyroxine withdrawal versus rhTSH administration: A retrospective comparison
Effect of 131I ‘clear residual thyroid tissue’ after surgery on the function of parathyroid gland in differentiated thyroid cancer
Iodine‑131 therapy alters the immune/inflammatory responses in the thyroids of patients with Graves' disease
Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients
Effects of iodine-131 radiotherapy on Th17/Tc17 and Treg/Th17 cells of patients with differentiated thyroid carcinoma